Perkins Coie Trust Co - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Perkins Coie Trust Co ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53
-57.3%
1780.0%0.00%
Q2 2023$124
-21.5%
1780.0%0.00%
Q1 2023$158
-24.0%
1780.0%0.00%
Q4 2022$208
-79.2%
1780.0%0.00%
Q3 2022$1,0000.0%1780.0%0.00%
Q2 2022$1,0000.0%1780.0%0.00%
Q1 2022$1,0000.0%1780.0%0.00%
Q4 2021$1,0000.0%1780.0%0.00%
Q3 2021$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2021$2,0000.0%1780.0%0.00%0.0%
Q1 2021$2,0000.0%1780.0%0.00%0.0%
Q4 2020$2,000
+100.0%
1780.0%0.00%
Q3 2020$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2020$2,000
+100.0%
1780.0%0.00%0.0%
Q1 2020$1,000
-66.7%
1780.0%0.00%0.0%
Q4 2019$3,000
+50.0%
1780.0%0.00%0.0%
Q3 2019$2,0000.0%1780.0%0.00%0.0%
Q2 2019$2,0000.0%1780.0%0.00%0.0%
Q1 2019$2,0000.0%1780.0%0.00%0.0%
Q4 2018$2,0000.0%1780.0%0.00%0.0%
Q3 2018$2,0000.0%1780.0%0.00%0.0%
Q2 2018$2,0000.0%1780.0%0.00%0.0%
Q1 2018$2,0000.0%1780.0%0.00%0.0%
Q4 2017$2,0000.0%1780.0%0.00%0.0%
Q3 2017$2,000
+100.0%
1780.0%0.00%0.0%
Q2 2017$1,000
-50.0%
1780.0%0.00%0.0%
Q1 2017$2,0001780.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders